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Abstract Predictive computational modelling in
biomedical research offers the potential to integrate diverse
data, uncover biological mechanisms that are not easily
accessible through experimental methods and expose gaps
in knowledge requiring further research. Recent develop-
ments in computing and diagnostic technologies have ini-
tiated the advancement of computational models in terms
of complexity and specificity. Consequently, computational
modelling can increasingly be utilised as enabling and
complementing modality in the clinic—with medical
decisions and interventions being personalised. Myocardial
infarction and heart failure are amongst the leading causes
of death globally despite optimal modern treatment. The
development of novel MI therapies is challenging and may
be greatly facilitated through predictive modelling. Here,
we review the advances in patient-specific modelling of
cardiac mechanics, distinguishing specificity in cardiac
geometry, myofibre architecture and mechanical tissue
properties. Thereafter, the focus narrows to the mechanics
of the infarcted heart and treatment of myocardial infarc-
tion with particular attention on intramyocardial biomate-
rial delivery.
Keywords Cardiac disease  Finite-element method 
Subject specific  Computational model  Ischaemic heart
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Introduction
Cardiovascular diseases are the single leading cause of
death worldwide, accounting for 30 % of all human mor-
tality [1]. Despite recent advances in pharmaceutical, sur-
gical, device and tissue-engineered therapy strategies,
cardiovascular diseases remain one of the most costly,
common and deadly medical conditions. Since predicted
mortality of cardiovascular diseases is projected to
increase, it is expected to remain the leading cause of death
globally [1, 2].
Computational models can provide a unique framework
for assessing efficacy of therapy approaches with relatively
low resources: Therapeutic parameters can be easily
modified and assessed in multiple concurrent in silico
experiments, and computational sensitivity studies are
easily conducted to optimise treatment efficacy. Advancing
research and technologies have sparked a great deal of
interest in integrating FE models into the clinical envi-
ronment. This is becoming more achievable each year,
making it likely that computational models will serve as
the first line of the screening for future therapies in the
years to come [3].
Reliable computational models can also provide a richer
source of information for clinical decision support and
treatment planning. Patient- and subject-specific computa-
tional modelling has been increasing at an exponential rate
(Fig. 1a), and sources of patient-specific genetic, anatom-
ical and physiological information are already being
incorporated in the clinical workflow [4–6].
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This review aims at contextualising the advances and
challenges of patient-specific computational modelling
with particular focus on cardiac and infarct mechanics and
the translation of therapeutic concepts, based on intramy-
ocardial biomaterial injections, for the myocardial infarc-
tion (MI) and infarct-induced heart failure (HF). The
developments in subject- and patient-specific modelling are
detailed with focus on cardiac geometries, myofibre
architecture and the constitutive properties of cardiac tis-
sue. Thereafter, the focus narrows on computational mod-
elling of infarct mechanics and therapies for MI, in
particular intramyocardial biomaterial injection.
Patient-specific modelling of cardiac mechanics
Cardiac geometries
Anatomical simplification needs to balance model accuracy
and computational demands. Until recently, this motivated
the use of simplified left ventricular (LV) geometries
introduced by various groups [7–9] as the primary com-
putational tool for investigating cardiac mechanics. The
use of patient-specific realistic geometries has, however,
become prevalent in computational models (Fig. 1b). This
shift towards realistic geometries is indicative of the goal to
create more representative computational models for use in
clinical decision support.
The first three-dimensional patient-specific computa-
tional geometry of a heart was introduced by Okajima et al.
[10] to study electrical activation. It took over two decades
for deformable computational finite-element (FE) approa-
ches to incorporate realistic heart geometries [11]. Nielsen
et al. [12] presented a realistic biventricular model that was
novel for its accurate geometric description and definition
of myofibre orientation. Stevens et al. [13] extended the
model to account, in part, for the four valves. Since then,
realistic geometrical models have become increasingly
popular. The Living Heart Project recently developed the
first full heart model that features a four-chamber human
heart geometry with the four valves and the connecting
large vessels [14].
To date, patient-specific cardiac geometries have been
introduced as representative cases as proof of concept that
a given computational approach can be applied in a patient-
specific framework. Extending the concept to computa-
tional studies with a large number of patient-specific
geometries could generate statistically meaningful results
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Fig. 1 Number of yearly
publications of peer-reviewed
journal articles a with ‘‘patient-
specific’’ or ‘‘subject-specific’’
contained in the title and b for
finite-element-based studies
focusing on cardiac ventricular
mechanics. Source: Thomson
Reuters ISI Web of
Knowledge and PubMed
databases, January 2016
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for a patient population. An alternative approach is to
utilise a statistically averaged geometry that is represen-
tative of a patient population [15].
Myofibre architecture
The myofibre orientation has a critical influence on cardiac
mechanics and electrophysiology. However, the descrip-
tion of myofibre orientation is a highly intricate and
sophisticated task, which has been the subject of substantial
historical disagreement [16–18]. The intricacy stems from
the complex multiscale branching and merging of cardiac
myocytes at microscopic scale, creating anisotropy at tissue
level that changes dramatically throughout the structure.
An accurate numerical portrayal of the myofibre architec-
ture needs to incorporate the one-dimensional directional
tangent of the myofibre and the description of the fibre
sheets [18–20] which influences both passive and active
material behaviour.
In recent work, two methods are predominant in
describing the myofibre orientation in patient-specific car-
diac models: Rule-based reconstructions and fibre orien-
tation derived from diffusion tensor magnetic resonance
imaging (DTMRI). Rule-based approaches typically
describe the fibre orientation analytically or through
aggregated experimental data, whereby a dense fibre ori-
entation field is constructed through interpolation functions
[21, 22]. This has recently been cast in the form of a
boundary value problem, whereby the fibre orientation is
prescribed along the surfaces of the ventricular structure
and solved for throughout the geometry [23]. Rule-based
reconstructions can be advantageous in their application to
highly irregular geometries and their efficient implemen-
tation. In DTMRI approaches, the myofibre orientation is
calculated from the eigenvectors of diffusion tensors. Due
to the challenges of in vivo cardiac DTMRI, this method is
often limited to a single post mortem data set. In this case,
the derived fibre orientations are projected (or mapped)
onto other subject- or patient-specific geometries obtained
from computed tomography (CT) or magnetic resonance
imaging (MRI) [24, 25]. Toussaint et al. [26] recently
captured in vivo patient-specific myofibre orientation data
and integrated these data in other LV models of other
patients. This approach involved diffeomorphic data
transformations between a realistic geometry and the pro-
late spheroidal coordinate system.
Considering the sensitivity of FE predictions to varia-
tions in fibre orientation [27–29], it is preferable to incor-
porate patient-specific DTMRI data whenever possible.
DTMRI is, however, still limited as the diffusion tensor
characterises only the mean myofibre structure in a voxel
volume. Improved accuracy may be achieved by increased
spatial resolution of the DTMRI scan or by including a
dispersion parameter accounting for the deviation of the
fibre orientation within in a voxel. Whereas homogenous
dispersion has been considered in modelling myocardial
tissue [30], dispersion at voxel scale has not yet been
considered. Toussaint et al. [26] in vivo DTMRI analysis is
the most advanced approach at present. No computational
models have investigated cardiac function using truly
individual patient-specific fibre orientation.
Constitutive properties
The first constitutive relationship for passive myocardial
behaviour, in the form of an exponential strain energy for-
mulation, has been credited to byYuan-ChengFung [31–33].
The first invariant-based constitutive model was described
byHumphrey andYin [34], introducing an additional ‘‘fibre-
specific’’ term to account for the material anisotropy,
although limited to transverse isotropy [32]. Costa et al. [35]
developed an extended orthotropic formulation featuring a
fibre-specific coordinate system and principal material
stiffness along the fibre, sheet and normal directions. With
minor modifications, the formulations are commonly rep-
resented as strain energy density function [36, 37]:
W ¼ 1
2
CeQ  1 þ Aincomp: ð1Þ
Here Q is a function of the material strains (usually Green–
Lagrange), often given as













where Eij are the components of the right Cauchy-Green
deformation tensor in local fibre coordinates and bij are the
corresponding material parameters. The strain energy
function in the exponential form can also be constructed by



















The notation and material parameters detailed by Hol-
zapfel and Ogden [38] have become the most widely used
form of a passive material law for cardiac mechanics, often
recalibrated with new material parameters [22, 39, 40]. The
incompressibility of the material is handled through a
penalty function Aincomp, of which multiple variations exist,
and which is often implemented through mixed formula-
tion methods, splitting the deformation into isochoric and
deviatoric components.
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The incorporation of active tension into a mathematical
description to capture the contractile behaviour of the heart
is a significant task. The most common approach, intro-
duced by Guccione et al. [41], relies on additive contri-
bution of the active stress to the overall material stress,
typically along the local fibre orientation. Active tension
can be constructed using various physiologically mean-
ingful parameters, which has been employed by many
studies [14, 39, 42, 43]. Another emerging approach
involves multiplicative decomposition of the tensor gradi-
ent of deformation [44–46], in a similar fashion to the
theory of volumetric growth. Multiplicative decomposition
is more mathematically robust, whereas the additive
approach can capture physiological phenomena more
meaningfully. The latter is due to a more flexible formu-
lation that allows for parameter calibration on a tensor
component level [44, 45]. Contractile material behaviour
can be coupled within an electromechanical framework,
whereby a more realistic excitation–contraction pattern is
incorporated into the model. Over the last decade, this
multi-physics coupling has been introduced with great
success in various computational models [47–53].
It is impossible to meaningfully determine the three-di-
mensional patient-specific material properties from ventricu-
lar pressure–volume relationships alone [54]. To remedy this,
the identification of suitable values for the constitutive
parameters (sometimes called calibration) often utilises
additional data. In vitro biaxial and shear stress–strain
experiments [55, 56] on cardiac tissue have been used to
calibrate numerous constitutive laws.The reliability of invitro
experiments may be questionable due to tissue damage or
disruption in the process of extraction [57]. Inclusion of
in vivo data in material calibration provides a more realistic
mechanical environment for loading and deformation [58].
Obtaining these stress–strain data from magnetic resonance
electrography (MRE) or tagged MRI provides additional
advantages whereby patient-specific information can be cap-
tured into the constitutive law through optimisation approa-
ches [24, 54, 59–61]. This approach has recently been
extended to additionally estimate infarct material parameters
[62, 63]. Considering the anatomical variability amongst
patients, it becomes increasingly attractive to calibrate mate-
rial laws for geometrically consistent in vivo data, i.e., local
stress–strain data for the same geometry and fibre distribu-
tion—an inherently patient- or subject-specific process that
can easily be adopted to handle cardiac pathologies, e.g., MI.
Modelling of MI treatments
Noninvasive assessment of the heart after MI is essential
for optimal treatment. Local wall stress, in particular, can
be a key factor in assessing cardiac function and predict
post-MI effects, yet wall stress cannot be measured sys-
tematically and quantitatively with clinical modalities [64].
Imaging techniques provide high accuracy information
regarding the strain distribution in the heart, yet cannot
provide local stress information. Laplace’s law, used to
estimate cardiac wall stress, makes considerable assump-
tions with respect to the cardiac structure and provides
considerably different results to anatomically accurate FE
models [65].
FE models have been labelled as the most versatile
approach for quantitatively predicting myocardial stress
and strain distributions [66, 67]. The effects of MI on
structure and function of the heart have received increasing
attention for FE modelling. The understanding of the
aforementioned is essential when developing a treatment to
restore cardiac function and to attenuate adverse post-in-
farct remodelling. Simulating MI in silico allows the
influence on heart to be directly quantified [46, 68–71],
providing deeper insight into the underlying mechanisms
involved. For example, by complementing a study on
dosage efficacy of the ACE inhibitor ramipril, FE models
showed that apical wall stress is an independent predictor
of ventricular remodelling [72].
Surgical ventricular restoration (SVR) has been the
focus of several computational studies [73–77]. The most
recent SVR studies [75, 76] provide examples for how FE
models with increased complexity can contribute to elu-
cidating physiological processes and guiding treatment
development. For the treatment of MI, Guccione et al. [78]
investigated a ‘‘myosplint’’ device aimed at restraining the
epicardium to prevent remodelling. Wenk et al. [79]
explored the Acorn CorCap cardiac support device as
treatment for dilated cardiomyopathy. Another ventricular
restoration approach relies on the Parachute device [80]
which was subject of a patient-specific FE study indicating
that the reduction in end-diastolic wall stress underlies the
therapeutic benefit [43]. Mitral valve regurgitation, a sec-
ondary adverse condition resulting from ventricular
remodelling, often following MI, has received recent
attention with increasingly sophisticated FE models
(Fig. 2) [81–84].
Modelling of material injection therapies for MI
There has been significant recent interest in intramyocar-
dial biomaterial injections as therapy for MI, whereby
predominantly the infarcted region of the heart is injected
with a biomaterial which aims to inhibit the adverse
remodelling that leads to HF. Injectable biomaterials are
showing promise in preclinical studies [85–92], resulting in
a range of improvements to cardiac repair, with respect to
wall thickness, ejection fraction and ventricular volume.
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Further research on the specific mechanisms by which
these biomaterials improve cardiac function is needed to
aid the development of more effective treatment.
Research into cardiac injection therapy has become
diverse due to the choice of injectable material and the
delivery method from a range of viable options [93, 94].
Due to this, the representation of intramyocardial bioma-
terial injectates in computational models relies on either
homogenisation approaches, whereby the injected material
is averaged in the description of the myocardium wall, or
through geometric approaches, whereby the injections are
considered separate inclusions embedded within the wall.
Homogenisation techniques have shown consistently
that bulking the myocardium with non-contractile material
was sufficient to offset post-MI geometric changes and,
consequently decrease stress in the myocardial wall
(Fig. 3) [95]. Material injections that result in increased
stiffness to the infarct region have also been shown to
lower stresses in the infarcted and healthy regions of the
heart in subject-specific ovine LV FE models [67] (Fig. 4)
and for idealised ellipsoid LV models [96]. Improvements
to cardiac function seen in the subject-specific ovine FE
model such as wall thickening and increased ejection
fraction [67] are consistent with in vitro and in vivo
experiments [97]. In a combined experimental and com-
putational study, Kichula et al. [98] used an ellipsoidal LV
FE model (Fig. 5) to quantify the anisotropic increase in
stiffness due to hydrogel injection and the reduction in
local and global wall stresses. Dorsey et al. [92] developed
subject-specific porcine LV FE models from cardiac MRI
data to estimate the in vivo diastolic material properties of
infarcted tissue with therapeutic hyaluronic acid-based
hydrogel injections.
For more viscous injectable materials or when the
mechanical effects of the injectate at a microstructural
level are being investigated [99–102], modelling the
injected material as a discrete inclusion more meaningfully
represents the mechanical considerations. Computational
studies have consistently shown the beneficial impact to
cardiac function from material injections of this nature.
Wenk et al. [99] studied in an ellipsoidal LV FE model the
optimal distribution of multiple spherical injectates.
Kortsmit et al. [101] and Miller et al. [100] modelled the
striated and bulk injectate distribution observed preclini-
cally [89, 90, 97], (Fig. 6a, b), as discrete sheet-like
structures embedded within the myocardium in a canine
Fig. 2 Patient-specific FE model for investigation of treatment of
mitral valve regurgitation. Reproduced with permission from Bail-
largeon et al. [115]
Fig. 3 FE prediction of midwall fibre stress in an ovine left ventricle
with anteroapical infarct without treatment (a) and with simulated
intramyocardial delivery 4.4 mL of biomaterial in four infarct border
zone locations indicated by arrows (b). Difference of midwall fibre
stress between the untreated infarct and treated infarct that demon-
strates the location of stress reduction in relation to the injection sites
(arrows) (c). Adapted with permission from Wall et al. [95]
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biventricular model and a human LV model, respectively.
These sheet-like hydrogel inclusions were shown to better
improve cardiac performance in the ischaemic infarct
stage, but bulk-like injectates were shown to be better at
improving LV function at the remodelling stage, comple-
menting an experimental study in rats which investigated
the effects of delayed gel-injection therapy [89]. Sirry et al.
[103] presented a more realistic microstructurally detailed
geometry of a striated polyethylene glycol hydrogel
injectate in an infarcted rat heart, similar to Fig. 6c.
Residual stress in the cardiac wall due to material
injections has only recently been considered. Using a
patient-specific LV FE model based on MRI data of a
patient with HF, ischaemic cardiomyopathy and hyper-
tension, Lee et al. [104] revealed a complex regional stress
field in vicinity of the a set of spherical hydrogel injectates
located equidistant between the base and the apex of the
LV (Fig. 7). These first results warrant further investigation
into the local changes the injections cause to tissue and
Fig. 4 Contour plots of fibre
stress in the lateral wall of an
ovine left ventricle with
untreated infarct at end diastole
(a) and end systole (b), and after
treatment by delivery of 2.6 mL
of a calcium hydroxyapatite-
based tissue filler distributed
over 20 evenly spaced injections
at end diastole (c) and end
systole (d). (Colour scales of the
end diastole panels are the
same, and colour scales of the
end systole panels are the
same). Adapted with permission
from Wenk et al. [67]
Fig. 5 Ellipsoidal LV FE model with 20 intramyocardial hydrogel
injectates. Adapted with permission from Kichula et al. [98]
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fibre structure, as well as the mechanisms responsible for
the clinically observed reduction in global stress [105].
Lee et al. [106] investigated a combination treatment of
biomaterial injections and coronary artery bypass grafting
with patient-specific models developed from MRI data of
three patients suffering with HF. Simulating a longitudinal
study with pre-treatment and three- and six-months post-
treatment time points revealed a more uniform distribution
and 35 % reduction in myofibre stress throughout the LV.
Discussion
Advances in patient-specific computational cardiac
mechanics over the last decade have been significant in
almost every aspect. The quality of imaging and segmen-
tation techniques coupled with increasing computational
resources have allowed for unprecedented growth. Geo-
metrically realistic multi-physics models are becoming the
new standard of computational cardiology. As structural
and functional data of the heart become more easily
available, the calibration and validation of these models
becomes more reliable.
Patient-specific models hold promise for personalising
diagnosis, treatment planning and therapy design. The
example of SVR emphasises that interventions based on
accurate patient-specific information have clear advantages
over treatments that are not personalised. Large-cohort
patient-specific computational studies, simulating treat-
ments in silico, will also be able to unlock novel and sta-
tistically meaningful findings for entire patient
populations—something that cannot be achieved with a
small number of computational models. The ability to re-
use computational models, perturb parameters and perform
Fig. 6 Histological
micrographs demonstrating the
distribution of a polyethylene
glycol hydrogel (appearing in
pink) delivered immediately
(a) and seven days (b) after
infarct induction in rat hearts
(nuclei appear blue, bar
represents 50 lm). Reproduced
with permission from Kadner
et al. [89]. Reconstructed 3D
geometry of a polyethylene
glycol hydrogel injectate with
microstructural details
reconstructed from histological
sections in a biventricular rat
heart geometry (c) (injectate
shown in pink)
Fig. 7 Patient-specific LV FE
model with 12 ellipsoidal
hydrogel injectates located
equidistant between the base
and the apex. Adapted with
permission from Lee et al. [104]
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sensitivity studies will not only provide an unprecedented
wealth of information in the aid of therapy design but can
also accelerate the translation of therapy approaches into
the clinical setting.
Despite these advantages, there has yet to be a single
high-resolution patient-specific computational cardiac
model, constructed and calibrated using data from a single
patient. Accounting for patient-specific myofibre structure
and calibrating material laws using comprehensive in vivo
data are still largely lacking in computational models
investigating cardiac mechanics.
While recent computational research on biomaterial
injection MI therapies has made substantial progress, more
work is needed to further elucidate the mechanisms
underlying the benefits observed. The local and global
changes in myocardial tissue structure after MI, including
necrosis, fibrosis and scar formation, and the representation
in computational models are one area that need to receive
increased attention. Pending availability of experimental
data, advanced numerical methods to model growth [107–
109] and tissue healing [110] may be adaptable to com-
putationally describe MI-related ‘‘reverse’’ growth and
remodelling. This will allow to study in more detail the
effects of biomaterial injectates on tissue changes which
may provide additional therapeutic cues. A related chal-
lenge is the realistic representation of in situ injectate
geometries, in particular when biomaterial infiltrates the
myocardium at microscopic level [89, 90, 97]. Also yet
unconsidered in computational models are injection ther-
apies with mechanobiological targets such as fibroblast
reprogramming [111, 112] and stem cell therapies [113,
114].
Conclusions
Realistic predictive patient-specific computational models
require comprehensive in vivo data for calibration and
validation. In the context of cardiac diseases and therapies,
current in vivo imaging technologies are not yet advanced
enough to provide such patient-specific data as part of the
clinical diagnostic modalities. Until cutting-edge modali-
ties such as in vivo cardiac DTMRI become more available
in the clinic routine, the pursuit of fully subject-specific
computational modelling remains limited to preclinical
research, where a richer resource of in vivo and ex vivo
data can be utilised. Subject-specific computational mod-
elling can, however, offer great potential to complement
experimental research and can play a crucial role in
advancing biomaterial injection therapies for MI.
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